Akebia Therapeutics | AKBA - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Akebia Therapeutics USD 155.55M 7.1M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Ardelyx USD 31.21M 36.79M 2026-03
Astellas Pharma JPY 281.6B 93.23B 2026-03
AstraZeneca USD 4.89B 2.67B 2026-06
Bayer EUR 4.29B 1.44B 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Celltrion KRW 56.79B 6.92B 2026-03
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Exelixis USD 281.45M 55.3M 2026-06
Fresenius Medical Care EUR 1.06B 177.89M 2026-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Ironwood Pharmaceuticals USD 220.47M 5.01M 2026-03
J&J USD 20.42B 1.27B 2026-06
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Lexicon Pharmaceuticals USD 38.09M 3.76M 2026-03
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 1.72B 185M 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Neuren Pharmaceuticals AUD 4.23M 1.68M 2025-12
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pharma Mar EUR 19.34M 29.53M 2026-06
Prothena USD 288.19M 41.27M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Qiagen NV USD 646.29M 192.72M 2026-03
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Zealand Pharma A/S 3.85B 727.54M 2026-03
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03